A dominant role for chemoattractant receptor-homologous molecule expressed on T helper type 2 (Th2) cells (CRTH2) in mediating chemotaxis of CRTH2+ CD4+ Th2 lymphocytes in response to mast cell supernatants

被引:46
作者
Gyles, Shan L. [1 ]
Xue, Luzheng [1 ]
Townsend, Elizabeth R. [1 ]
Wettey, Frank [1 ]
Pettipher, Roy [1 ]
机构
[1] Oxagen Ltd, Dept Drug Discovery, Abingdon OX14 4RY, Oxon, England
关键词
CRTH2; mast cells; prostaglandin D-2; ramatroban; T helper type 2 lymphocytes;
D O I
10.1111/j.1365-2567.2006.02440.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human cultured mast cells, immunologically activated with immunoglobuin E (IgE)/anti-IgE, released a factor(s) that promoted chemotaxis of human CRTH2(+) CD4(+) T helper type 2 (Th2) lymphocytes. Mast cell supernatants collected at 20 min, 1 hr, 2 hr and 4 hr after activation caused a concentration-dependent increase in the migration of Th2 cells. The effect of submaximal dilutions of mast-cell-conditioned media was inhibited in a dose-dependent manner by ramatroban (IC50 = 96 nM), a dual antagonist of both the thromboxane-like prostanoid (TP) receptor and the chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2), but not by the selective TP antagonist SQ29548, implicating CRTH2 in mediating the chemotactic response of these Th2 cells. The effect of mast-cell-conditioned media was mimicked by prostaglandin D-2 (PGD(2)) and this eicosanoid was detected in the conditioned media from activated mast cells in concentrations sufficient to account for the activity of the mast cell supernatants. Treatment of the mast cells with the cyclo-oxygenase inhibitor diclofenac (10 mu M) inhibited both the production of PGD(2) and the CRTH2(+) CD4(+) Th2-stimulatory activity, while addition of exogenous PGD2 to conditioned media from diclofenac-treated mast cells restored the ability of the supernatants to promote chemotaxis of these Th2 cells. The degree of inhibition caused by diclofenac treatment of the mast cells was concordant with the degree of inhibition of chemotactic responses afforded by CRTH2 blockade. These data suggest that PGD(2), or closely related metabolites of arachidonic acid, produced from mast cells may play a central role in the activation of CRTH2(+) CD4(+) Th2 lymphocytes through a CRTH2-dependent mechanism.
引用
收藏
页码:362 / 368
页数:7
相关论文
共 31 条
[1]   The role of mast cells in asthma [J].
Boyce, JA .
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2003, 69 (2-3) :195-205
[2]   INTERLEUKIN-4, INTERLEUKIN-5, AND INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA IN NORMAL AND ASTHMATIC AIRWAYS - EVIDENCE FOR THE HUMAN MAST-CELL AS A SOURCE OF THESE CYTOKINES [J].
BRADDING, P ;
ROBERTS, JA ;
BRITTEN, KM ;
MONTEFORT, S ;
DJUKANOVIC, R ;
MUELLER, R ;
HEUSSER, CH ;
HOWARTH, PH ;
HOLGATE, ST .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1994, 10 (05) :471-480
[3]   New insights into the role of the mast cell in asthma [J].
Brightling, CE ;
Bradding, P ;
Pavord, ID ;
Wardlaw, AJ .
CLINICAL AND EXPERIMENTAL ALLERGY, 2003, 33 (05) :550-556
[4]   TRYPTASE AND CHYMASE, MARKERS OF DISTINCT TYPES OF HUMAN MAST-CELLS [J].
CRAIG, SS ;
SCHWARTZ, LB .
IMMUNOLOGIC RESEARCH, 1989, 8 (02) :130-148
[5]   Monitoring mast cell activation by prostaglandin D2 in vivo [J].
Dahlèn, SE ;
Kumlin, M .
THORAX, 2004, 59 (06) :453-455
[6]   Human synovial mast cells .2. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs [J].
dePaulis, A ;
Ciccarelli, A ;
Marino, I ;
deCrescenzo, G ;
Marino, D ;
Marone, G .
ARTHRITIS AND RHEUMATISM, 1997, 40 (03) :469-478
[7]   Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma [J].
Djukanovic, R ;
Wilson, SJ ;
Kraft, M ;
Jarjour, NN ;
Steel, M ;
Chung, KF ;
Bao, WB ;
Fowler-Taylor, A ;
Matthews, J ;
Busse, WW ;
Holgate, ST ;
Fahy, JV .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (06) :583-593
[8]   Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice [J].
Fujitani, Y ;
Kanaoka, Y ;
Aritake, K ;
Uodome, N ;
Okazaki-Hatake, K ;
Urade, Y .
JOURNAL OF IMMUNOLOGY, 2002, 168 (01) :443-449
[9]   Δ12-Prostaglandin D2 is a potent and selective CRTH2 receptor agonist and causes activation of human eosinophils and Th2 lymphocytes [J].
Gazi, L ;
Gyles, S ;
Rose, J ;
Lees, S ;
Allan, C ;
Xue, LZ ;
Jassal, R ;
Speight, G ;
Gamble, V ;
Pettipher, R .
PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2005, 75 (1-4) :153-167
[10]   THE CLASSIFICATION OF PROSTAGLANDIN DP-RECEPTORS IN PLATELETS AND VASCULATURE USING BW-A868C, A NOVEL, SELECTIVE AND POTENT COMPETITIVE ANTAGONIST [J].
GILES, H ;
LEFF, P ;
BOLOFO, ML ;
KELLY, MG ;
ROBERTSON, AD .
BRITISH JOURNAL OF PHARMACOLOGY, 1989, 96 (02) :291-300